▶ 調査レポート

ヘパリンナトリウム注射の世界市場レポート2020

• 英文タイトル:Covid-19 Impact on Global Heparin Sodium Injection Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ヘパリンナトリウム注射の世界市場レポート2020 / Covid-19 Impact on Global Heparin Sodium Injection Sales Market Report 2020 / 20QY06-03628資料のイメージです。• レポートコード:20QY06-03628
• 出版社/出版日:QYResearch / 2020年6月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、145ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ヘパリンナトリウム注射のグローバル市場について種類別(1000USP単位/mL、5000USP単位/mL、10000USP単位/mL)、用途別(静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッターカーディオバージョン、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ヘパリンナトリウム注射市場の概要
・世界の主要地域別ヘパリンナトリウム注射市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のヘパリンナトリウム注射市場規模2015-2026:種類別(1000USP単位/mL、5000USP単位/mL、10000USP単位/mL)
・世界のヘパリンナトリウム注射市場規模2015-2026:用途別(静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッターカーディオバージョン、その他)
・ヘパリンナトリウム注射の北米市場規模2015-2020
・ヘパリンナトリウム注射のヨーロッパ市場規模2015-2020
・ヘパリンナトリウム注射の中国市場規模2015-2020
・ヘパリンナトリウム注射の日本市場規模2015-2020
・ヘパリンナトリウム注射の東南アジア市場規模2015-2020
・ヘパリンナトリウム注射のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Shenzhen Hepalink、Bioibérica、Nanjing King-friend、Pfizer、Dongcheng Biochemicals、Changzhou Qianhong Bio-pharma、Changshan Biochemical、Pharma Action、Baxter、Dongying Tiandong Pharmaceutical、Opocrin、Aspen Oss、Xinbai Pharmaceuticals、Yino Pharma Limited、Sichuan Deebio)
・ヘパリンナトリウム注射の製造コスト分析
・販売チャネル、流通業者、顧客
・ヘパリンナトリウム注射の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Heparin Sodium Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Heparin Sodium Injection market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Heparin Sodium Injection market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Heparin Sodium Injection industry.
Based on our recent survey, we have several different scenarios about the Heparin Sodium Injection YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Heparin Sodium Injection will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Heparin Sodium Injection market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Heparin Sodium Injection market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Heparin Sodium Injection market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Heparin Sodium Injection market. The report also includes nautical information, where it shows Heparin Sodium Injection market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Heparin Sodium Injection market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Heparin Sodium Injection market.
Geographical Analysis:
Based on region, the global Heparin Sodium Injection market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Heparin Sodium Injection market are
Shenzhen Hepalink
Bioibérica
Nanjing King-friend
Pfizer
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio
Segment by Type
1,000 USP Units / mL
5,000 USP Units / mL
10,000 USP Units / mL
Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Heparin Sodium Injection market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Heparin Sodium Injection market.
• The market share of the global Heparin Sodium Injection market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Heparin Sodium Injection market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Heparin Sodium Injection market.

レポート目次

1 Heparin Sodium Injection Market Overview
1.1 Heparin Sodium Injection Product Scope
1.2 Heparin Sodium Injection Segment by Type
1.2.1 Global Heparin Sodium Injection Sales by Type (2020-2026)
1.2.2 1,000 USP Units / mL
1.2.3 5,000 USP Units / mL
1.2.4 10,000 USP Units / mL
1.3 Heparin Sodium Injection Segment by Application
1.3.1 Global Heparin Sodium Injection Sales Comparison by Application (2020-2026)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Other
1.4 Heparin Sodium Injection Market Estimates and Forecasts (2015-2026)
1.4.1 Global Heparin Sodium Injection Sales Growth Rate (2015-2026)
1.4.2 Global Heparin Sodium Injection Revenue and Growth Rate (2015-2026)
1.4.3 Global Heparin Sodium Injection Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Heparin Sodium Injection Industry Impact
1.5.1 How the Covid-19 is Affecting the Heparin Sodium Injection Industry
1.5.1.1 Heparin Sodium Injection Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Heparin Sodium Injection Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Heparin Sodium Injection Players to Combat Covid-19 Impact

2 Heparin Sodium Injection Estimate and Forecast by Region
2.1 Global Heparin Sodium Injection Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Heparin Sodium Injection Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Heparin Sodium Injection Sales Market Share by Region (2015-2020)
2.2.2 Global Heparin Sodium Injection Revenue Market Share by Region (2015-2020)
2.3 Global Heparin Sodium Injection Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Heparin Sodium Injection Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Heparin Sodium Injection Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Heparin Sodium Injection Estimates and Projections (2015-2026)
2.4.2 Europe Heparin Sodium Injection Estimates and Projections (2015-2026)
2.4.3 China Heparin Sodium Injection Estimates and Projections (2015-2026)
2.4.4 Japan Heparin Sodium Injection Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Heparin Sodium Injection Estimates and Projections (2015-2026)
2.4.6 India Heparin Sodium Injection Estimates and Projections (2015-2026)
3 Global Heparin Sodium Injection Competition Landscape by Players
3.1 Global Top Heparin Sodium Injection Players by Sales (2015-2020)
3.2 Global Top Heparin Sodium Injection Players by Revenue (2015-2020)
3.3 Global Heparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin Sodium Injection as of 2019)
3.4 Global Heparin Sodium Injection Average Price by Company (2015-2020)
3.5 Manufacturers Heparin Sodium Injection Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Heparin Sodium Injection Players (Opinion Leaders)
4 Global Heparin Sodium Injection Market Size by Type
4.1 Global Heparin Sodium Injection Historic Market Review by Type (2015-2020)
4.1.1 Global Heparin Sodium Injection Sales Market Share by Type (2015-2020)
4.1.2 Global Heparin Sodium Injection Revenue Market Share by Type (2015-2020)
4.1.3 Global Heparin Sodium Injection Price by Type (2014-2020)
4.2 Global Heparin Sodium Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Heparin Sodium Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Heparin Sodium Injection Revenue Forecast by Type (2021-2026)
4.2.3 Global Heparin Sodium Injection Price Forecast by Type (2021-2026)
5 Global Heparin Sodium Injection Market Size by Application
5.1 Global Heparin Sodium Injection Historic Market Review by Application (2015-2020)
5.1.1 Global Heparin Sodium Injection Sales Market Share by Application (2015-2020)
5.1.2 Global Heparin Sodium Injection Revenue Market Share by Application (2015-2020)
5.1.3 Global Heparin Sodium Injection Price by Application (2015-2020)
5.2 Global Heparin Sodium Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Heparin Sodium Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Heparin Sodium Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Heparin Sodium Injection Price Forecast by Application (2021-2026)

3 North America Heparin Sodium Injection Market Facts & Figures
3.2 North America Heparin Sodium Injection Sales Market Share by Company (2015-2020)
3.3 North America Heparin Sodium Injection Sales Market Share by Type (2015-2020)
3.4 North America Heparin Sodium Injection Sales Market Share by Application (2015-2020)

4 Europe Heparin Sodium Injection Market Facts & Figures
4.2 Europe Heparin Sodium Injection Sales Market Share by Company (2015-2020)
4.3 Europe Heparin Sodium Injection Sales Market Share by Type (2015-2020)
4.4 Europe Heparin Sodium Injection Sales Market Share by Application (2015-2020)

5 China Heparin Sodium Injection Market Facts & Figures
5.2 China Heparin Sodium Injection Sales Market Share by Company (2015-2020)
5.3 China Heparin Sodium Injection Sales Market Share by Type (2015-2020)
5.4 China Heparin Sodium Injection Sales Market Share by Application (2015-2020)

6 Japan Heparin Sodium Injection Market Facts & Figures
6.2 Japan Heparin Sodium Injection Sales Market Share by Company (2015-2020)
6.3 Japan Heparin Sodium Injection Sales Market Share by Type (2015-2020)
6.4 Japan Heparin Sodium Injection Sales Market Share by Application (2015-2020)

7 Southeast Asia Heparin Sodium Injection Market Facts & Figures
7.2 Southeast Asia Heparin Sodium Injection Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Heparin Sodium Injection Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Heparin Sodium Injection Sales Market Share by Application (2015-2020)

8 India Heparin Sodium Injection Market Facts & Figures
8.2 India Heparin Sodium Injection Sales Market Share by Company (2015-2020)
8.3 India Heparin Sodium Injection Sales Market Share by Type (2015-2020)
8.4 India Heparin Sodium Injection Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Heparin Sodium Injection Business
12.1 Shenzhen Hepalink
12.1.1 Shenzhen Hepalink Heparin Sodium Injection Corporation Information
12.1.2 Shenzhen Hepalink Heparin Sodium Injection Business Overview and Total Revenue
12.1.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Shenzhen Hepalink Heparin Sodium Injection Products Offered
12.1.5 Shenzhen Hepalink Recent Development
12.2 Bioibérica
12.2.1 Bioibérica Heparin Sodium Injection Corporation Information
12.2.2 Bioibérica Heparin Sodium Injection Business Overview and Total Revenue
12.2.3 Bioibérica Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bioibérica Heparin Sodium Injection Products Offered
12.2.5 Bioibérica Recent Development
12.3 Nanjing King-friend
12.3.1 Nanjing King-friend Heparin Sodium Injection Corporation Information
12.3.2 Nanjing King-friend Heparin Sodium Injection Business Overview and Total Revenue
12.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Nanjing King-friend Heparin Sodium Injection Products Offered
12.3.5 Nanjing King-friend Recent Development
12.4 Pfizer
12.4.1 Pfizer Heparin Sodium Injection Corporation Information
12.4.2 Pfizer Heparin Sodium Injection Business Overview and Total Revenue
12.4.3 Pfizer Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Heparin Sodium Injection Products Offered
12.4.5 Pfizer Recent Development
12.5 Dongcheng Biochemicals
12.5.1 Dongcheng Biochemicals Heparin Sodium Injection Corporation Information
12.5.2 Dongcheng Biochemicals Heparin Sodium Injection Business Overview and Total Revenue
12.5.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dongcheng Biochemicals Heparin Sodium Injection Products Offered
12.5.5 Dongcheng Biochemicals Recent Development
12.6 Changzhou Qianhong Bio-pharma
12.6.1 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Corporation Information
12.6.2 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Business Overview and Total Revenue
12.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Products Offered
12.6.5 Changzhou Qianhong Bio-pharma Recent Development
12.7 Changshan Biochemical
12.7.1 Changshan Biochemical Heparin Sodium Injection Corporation Information
12.7.2 Changshan Biochemical Heparin Sodium Injection Business Overview and Total Revenue
12.7.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changshan Biochemical Heparin Sodium Injection Products Offered
12.7.5 Changshan Biochemical Recent Development
12.8 Pharma Action
12.8.1 Pharma Action Heparin Sodium Injection Corporation Information
12.8.2 Pharma Action Heparin Sodium Injection Business Overview and Total Revenue
12.8.3 Pharma Action Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pharma Action Heparin Sodium Injection Products Offered
12.8.5 Pharma Action Recent Development
12.9 Baxter
12.9.1 Baxter Heparin Sodium Injection Corporation Information
12.9.2 Baxter Heparin Sodium Injection Business Overview and Total Revenue
12.9.3 Baxter Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Baxter Heparin Sodium Injection Products Offered
12.9.5 Baxter Recent Development
12.10 Dongying Tiandong Pharmaceutical
12.10.1 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Corporation Information
12.10.2 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Business Overview and Total Revenue
12.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Products Offered
12.10.5 Dongying Tiandong Pharmaceutical Recent Development
12.11 Opocrin
12.11.1 Opocrin Heparin Sodium Injection Corporation Information
12.11.2 Opocrin Heparin Sodium Injection Business Overview and Total Revenue
12.11.3 Opocrin Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Opocrin Heparin Sodium Injection Products Offered
12.11.5 Opocrin Recent Development
12.12 Aspen Oss
12.12.1 Aspen Oss Heparin Sodium Injection Corporation Information
12.12.2 Aspen Oss Heparin Sodium Injection Business Overview and Total Revenue
12.12.3 Aspen Oss Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Aspen Oss Heparin Sodium Injection Products Offered
12.12.5 Aspen Oss Recent Development
12.13 Xinbai Pharmaceuticals
12.13.1 Xinbai Pharmaceuticals Heparin Sodium Injection Corporation Information
12.13.2 Xinbai Pharmaceuticals Heparin Sodium Injection Business Overview and Total Revenue
12.13.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Xinbai Pharmaceuticals Heparin Sodium Injection Products Offered
12.13.5 Xinbai Pharmaceuticals Recent Development
12.14 Yino Pharma Limited
12.14.1 Yino Pharma Limited Heparin Sodium Injection Corporation Information
12.14.2 Yino Pharma Limited Heparin Sodium Injection Business Overview and Total Revenue
12.14.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Yino Pharma Limited Heparin Sodium Injection Products Offered
12.14.5 Yino Pharma Limited Recent Development
12.15 Sichuan Deebio
12.15.1 Sichuan Deebio Heparin Sodium Injection Corporation Information
12.15.2 Sichuan Deebio Heparin Sodium Injection Business Overview and Total Revenue
12.15.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sichuan Deebio Heparin Sodium Injection Products Offered
12.15.5 Sichuan Deebio Recent Development

13 Heparin Sodium Injection Manufacturing Cost Analysis
13.1 Heparin Sodium Injection Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Heparin Sodium Injection
13.4 Heparin Sodium Injection Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Heparin Sodium Injection Distributors List
14.3 Heparin Sodium Injection Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Heparin Sodium Injection Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Heparin Sodium Injection Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Heparin Sodium Injection Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Heparin Sodium Injection Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Heparin Sodium Injection Players to Combat Covid-19 Impact
Table 8. Global Market Heparin Sodium Injection Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Heparin Sodium Injection Sales (Kg) by Region (2015-2020)
Table 10. Global Heparin Sodium Injection Sales Market Share by Region (2015-2020)
Table 11. Global Heparin Sodium Injection Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Heparin Sodium Injection Revenue Share by Region (2015-2020)
Table 13. Global Heparin Sodium Injection Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Heparin Sodium Injection Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Heparin Sodium Injection Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Heparin Sodium Injection Revenue Share Forecast by Region (2021-2026)
Table 17. Global Heparin Sodium Injection (Kg) of Key Companies (2015-2020)
Table 18. Global Heparin Sodium Injection Sales Share by Company (2015-2020)
Table 19. Global Heparin Sodium Injection Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Heparin Sodium Injection Revenue Share by Company (2015-2020)
Table 21. Global Heparin Sodium Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin Sodium Injection as of 2019)
Table 22. Global Heparin Sodium Injection Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Heparin Sodium Injection Manufacturing Sites and Area Served
Table 24. Manufacturers Heparin Sodium Injection Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Heparin Sodium Injection Players
Table 27. Global Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 28. Global Heparin Sodium Injection Sales Share by Type (2015-2020)
Table 29. Global Heparin Sodium Injection Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Heparin Sodium Injection Price (Kg) by Type (2015-2020)
Table 31. Global Heparin Sodium Injection Sales Share by Type (2021-2026)
Table 32. Global Heparin Sodium Injection Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Heparin Sodium Injection Revenue Share by Type (2021-2026)
Table 34. Global Heparin Sodium Injection Price (Kg) by Type (2021-2026)
Table 35. Global Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 36. Global Heparin Sodium Injection Sales Share by Application (2015-2020)
Table 37. Global Heparin Sodium Injection Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Heparin Sodium Injection Price (Kg) by Application (2015-2020)
Table 39. Global Heparin Sodium Injection Sales (Kg) by Application (2021-2026)
Table 40. Global Heparin Sodium Injection Sales Share by Application (2021-2026)
Table 41. Global Heparin Sodium Injection Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Heparin Sodium Injection Revenue Share by Application (2021-2026)
Table 43. Global Heparin Sodium Injection Price (Kg) by Application (2021-2026)
Table 44. United States Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 45. United States Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 46. United States Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 47. United States Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 48. United States Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 49. United States Heparin Sodium Injection Sales Market Share by Application (2015-2020)
Table 50. Europe Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 51. Europe Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 52. Europe Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 53. Europe Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 54. Europe Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 55. Europe Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 56. China Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 57. China Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 58. China Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 59. China Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 60. China Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 61. China Heparin Sodium Injection Sales Market Share by Application (2015-2020)
Table 62. Japan Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 63. Japan Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 64. Japan Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 65. Japan Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 66. Japan Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 67. Japan Heparin Sodium Injection Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Heparin Sodium Injection Sales Market Share by Application (2015-2020)
Table 74. India Heparin Sodium Injection Sales (Kg) by Company (2015-2020)
Table 75. India Heparin Sodium Injection Sales Market Share by Company (2015-2020)
Table 76. India Heparin Sodium Injection Sales (Kg) by Type (2015-2020)
Table 77. India Heparin Sodium Injection Sales Market Share by Type (2015-2020)
Table 78. India Heparin Sodium Injection Sales (Kg) by Application (2015-2020)
Table 79. India Heparin Sodium Injection Sales Market Share by Application (2015-2020)
Table 80. Shenzhen Hepalink Corporation Information
Table 81. Shenzhen Hepalink Description and Business Overview
Table 82. Shenzhen Hepalink Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Shenzhen Hepalink Heparin Sodium Injection Product
Table 84. Shenzhen Hepalink Recent Development
Table 85. Bioibérica Corporation Information
Table 86. Bioibérica Description and Business Overview
Table 87. Bioibérica Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Bioibérica Heparin Sodium Injection Product
Table 89. Bioibérica Recent Development
Table 90. Nanjing King-friend Corporation Information
Table 91. Nanjing King-friend Description and Business Overview
Table 92. Nanjing King-friend Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Nanjing King-friend Heparin Sodium Injection Product
Table 94. Nanjing King-friend Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Pfizer Heparin Sodium Injection Product
Table 99. Pfizer Recent Development
Table 100. Dongcheng Biochemicals Corporation Information
Table 101. Dongcheng Biochemicals Description and Business Overview
Table 102. Dongcheng Biochemicals Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Dongcheng Biochemicals Heparin Sodium Injection Product
Table 104. Dongcheng Biochemicals Recent Development
Table 105. Changzhou Qianhong Bio-pharma Corporation Information
Table 106. Changzhou Qianhong Bio-pharma Description and Business Overview
Table 107. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product
Table 109. Changzhou Qianhong Bio-pharma Recent Development
Table 110. Changshan Biochemical Corporation Information
Table 111. Changshan Biochemical Description and Business Overview
Table 112. Changshan Biochemical Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Changshan Biochemical Heparin Sodium Injection Product
Table 114. Changshan Biochemical Recent Development
Table 115. Pharma Action Corporation Information
Table 116. Pharma Action Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Pharma Action Description and Business Overview
Table 118. Pharma Action Heparin Sodium Injection Product
Table 119. Pharma Action Recent Development
Table 120. Baxter Corporation Information
Table 121. Baxter Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Baxter Description and Business Overview
Table 123. Baxter Heparin Sodium Injection Product
Table 124. Baxter Recent Development
Table 125. Dongying Tiandong Pharmaceutical Corporation Information
Table 126. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 127. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product
Table 129. Dongying Tiandong Pharmaceutical Recent Development
Table 130. Opocrin Corporation Information
Table 131. Opocrin Description and Business Overview
Table 132. Opocrin Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Opocrin Heparin Sodium Injection Product
Table 134. Opocrin Recent Development
Table 135. Aspen Oss Corporation Information
Table 136. Aspen Oss Description and Business Overview
Table 137. Aspen Oss Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Aspen Oss Heparin Sodium Injection Product
Table 139. Aspen Oss Recent Development
Table 140. Xinbai Pharmaceuticals Corporation Information
Table 141. Xinbai Pharmaceuticals Description and Business Overview
Table 142. Xinbai Pharmaceuticals Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. Xinbai Pharmaceuticals Heparin Sodium Injection Product
Table 144. Xinbai Pharmaceuticals Recent Development
Table 145. Yino Pharma Limited Corporation Information
Table 146. Yino Pharma Limited Description and Business Overview
Table 147. Yino Pharma Limited Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Yino Pharma Limited Heparin Sodium Injection Product
Table 149. Yino Pharma Limited Recent Development
Table . Sichuan Deebio Corporation Information
Table . Sichuan Deebio Description and Business Overview
Table . Sichuan Deebio Heparin Sodium Injection Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Sichuan Deebio Heparin Sodium Injection Product
Table . Sichuan Deebio Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Heparin Sodium Injection Distributors List
Table 158. Heparin Sodium Injection Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Sodium Injection Product Picture
Figure 2. Global Heparin Sodium Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Heparin Sodium Injection Market Share by Application in 2020 & 2026
Figure 6. Treatment of Venous Thromboembolism Examples
Figure 7. Complications of Pregnancy Examples
Figure 8. Cardioversion of Atrial Fibrillation/Flutter Examples
Figure 9. Other Examples
Figure 10. Global Heparin Sodium Injection Sales (Kg) Growth Rate (2015-2026)
Figure 11. Global Heparin Sodium Injection Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Heparin Sodium Injection Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Heparin Sodium Injection Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Heparin Sodium Injection Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Heparin Sodium Injection Sales (Kg) Growth Rate (2015-2026)
Figure 17. Europe Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Heparin Sodium Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Heparin Sodium Injection Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Heparin Sodium Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Heparin Sodium Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Heparin Sodium Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Heparin Sodium Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Heparin Sodium Injection Players Market Share by Revenue in Heparin Sodium Injection 2015 & 2019
Figure 28. Heparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Heparin Sodium Injection Revenue Share by Type (2015-2020)
Figure 30. Global Heparin Sodium Injection Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Heparin Sodium Injection Revenue Share by Application (2015-2020)
Figure 32. Global Heparin Sodium Injection Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 34. United States Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 35. Europe Heparin Sodium Injection Sales Market Share by Company in 2019
Figure 36. Europe Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 37. Europe Heparin Sodium Injection Sales Market Share by Application in 2019
Figure 38. China Heparin Sodium Injection Sales Market Share by Company in 2019
Figure 39. China Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 40. China Heparin Sodium Injection Sales Market Share by Application in 2019
Figure 41. Japan Heparin Sodium Injection Sales Market Share by Company in 2019
Figure 42. Japan Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 43. Japan Heparin Sodium Injection Sales Market Share by Application in 2019
Figure 44. Southeast Asia Heparin Sodium Injection Sales Market Share by Company in 2019
Figure 45. Southeast Asia Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 46. Southeast Asia Heparin Sodium Injection Sales Market Share by Application in 2019
Figure 47. India Heparin Sodium Injection Sales Market Share by Company in 2019
Figure 48. India Heparin Sodium Injection Sales Market Share by Type in 2019
Figure 49. India Heparin Sodium Injection Sales Market Share by Application in 2019
Figure 50. Shenzhen Hepalink Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bioibérica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Nanjing King-friend Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Dongcheng Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Changzhou Qianhong Bio-pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Changshan Biochemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pharma Action Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dongying Tiandong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Opocrin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Aspen Oss Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Xinbai Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Yino Pharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Sichuan Deebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Heparin Sodium Injection
Figure 67. Manufacturing Process Analysis of Heparin Sodium Injection
Figure 68. Heparin Sodium Injection Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed